Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 1

Results: 31

Abstracts.

Published in:: Cancer Science, 2024, v. 115, n. 1, p. 1, doi. 10.1111/cas.16114
Publication type:: Article

In this issue: Volume 115, Issue 1, January 2024.

Published in:: Cancer Science, 2024, v. 115, n. 1, p. 5, doi. 10.1111/cas.16071
Publication type:: Article

Correction to: Steroid receptor coactivator‐1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR‐152/KLF4 pathway.

Published in:: Cancer Science, 2024, v. 115, n. 1, p. 324, doi. 10.1111/cas.16026
Publication type:: Article

Role and function of plakophilin 3 in cancer progression and skin disease.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 17, doi. 10.1111/cas.16019

By:

Zhang, Yefei;
Chen, Jiahui;
Tian, Jia;
Zhou, Yehui;
Liu, Yan

Publication type:

Article

Retraction: Cui S‐Z, Lei Z‐Y, Guan T–P, et al. Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy. Cancer Science. 2020; 111: 1567–1581. https://doi.org/10.1111/cas.14375.

Published in:: Cancer Science, 2024, v. 115, n. 1, p. 325, doi. 10.1111/cas.16018
Publication type:: Article

Neon ion (20Ne10+) charged particle beams manipulate rapid tumor reoxygenation in syngeneic mouse models.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 227, doi. 10.1111/cas.16017

By:

Imaizumi, Akiko;
Hirayama, Ryoichi;
Ikoma, Yoko;
Nitta, Nobuhiro;
Obata, Takayuki;
Hasegawa, Sumitaka

Publication type:

Article

Serial comprehensive genomic profiling by next‐generation sequencing for patients with metastatic colorectal cancer.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 321, doi. 10.1111/cas.16016

By:

Olsen, Steven;
Nakamura, Yoshiaki

Publication type:

Article

A novel iTreg‐related signature for prognostic prediction in lung adenocarcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 109, doi. 10.1111/cas.16015

By:

Zhang, Jian;
Li, Yan;
Yang, Yue;
Huang, Jian;
Sun, Yue;
Zhang, Xi;
Kong, Xianglong

Publication type:

Article

Antitumor activities against breast cancers by an afucosylated anti‐HER2 monoclonal antibody H2Mab‐77‐mG2a‐f.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 298, doi. 10.1111/cas.16008

By:

Tanaka, Tomohiro;
Suzuki, Hiroyuki;
Ohishi, Tomokazu;
Kaneko, Mika K.;
Kato, Yukinari

Publication type:

Article

T‐cell receptor sequencing reveals hepatocellular carcinoma immune characteristics according to Barcelona Clinic liver cancer stages within liver tissue and peripheral blood.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 94, doi. 10.1111/cas.16013

By:

Li, Rui;
Wang, Junxiao;
Li, Xiubin;
Liang, Yining;
Jiang, Yiyun;
Zhang, Yuwei;
Xu, Pengfei;
Deng, Ling;
Wang, Zhe;
Sun, Tao;
Wu, Jian;
Xie, Hui;
Wang, Yijin

Publication type:

Article

Detection and clinical significance of CEACAM5 methylation in colorectal cancer patients.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 270, doi. 10.1111/cas.16012

By:

Huang, Sheng‐Chieh;
Chang, Shih‐Ching;
Liao, Tsai‐Tsen;
Yang, Muh‐Hwa

Publication type:

Article

Autoantibody repertoire profiling in tissue and blood identifies colorectal cancer‐specific biomarkers.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 83, doi. 10.1111/cas.16011

By:

Zhang, Pei‐Fen;
Wu, Ziyi;
Zhou, Ting;
Yang, Da‐Wei;
Mu, Quan‐Kai;
Zhang, Wen‐Bin;
Yu, Long;
Zhang, Shao‐Dan;
Hu, Ye‐Zhu;
Mu, Jianbing;
Jia, Wei‐Hua

Publication type:

Article

Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 257, doi. 10.1111/cas.16009

By:

Lv, Yang;
Zheng, Peng;
Mao, Yihao;
Xu, Yuqiu;
Chang, Wenju;
Lin, Qi;
Ji, Meiling;
Ye, Lechi;
Tang, Wentao;
Xu, Jianmin

Publication type:

Article

Extracellular vesicle‐encapsulated microRNA‐296‐3p from cancer‐associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 155, doi. 10.1111/cas.16014

By:

Sun, Luyao;
Ke, Miaola;
Yin, Mengyuan;
Zeng, Ying;
Ji, Yutong;
Hu, Yiming;
Fu, Songbin;
Zhang, Chunyu

Publication type:

Article

LINE‐1 hypomethylation, increased retrotransposition and tumor‐specific insertion in upper gastrointestinal cancer.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 247, doi. 10.1111/cas.16007

By:

Baba, Yoshifumi;
Yasuda, Noriko;
Bundo, Miki;
Nakachi, Yutaka;
Ueda, Junko;
Ishimoto, Takatsugu;
Iwatsuki, Masaaki;
Miyamoto, Yuji;
Yoshida, Naoya;
Oshiumi, Hiroyuki;
Iwamoto, Kazuya;
Baba, Hideo

Publication type:

Article

Inhibition of transforming growth factor‐β signals suppresses tumor formation by regulation of tumor microenvironment networks.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 211, doi. 10.1111/cas.16006

By:

Tokizaki, Shiori;
Podyma‐Inoue, Katarzyna A.;
Matsumoto, Takehisa;
Takahashi, Kazuki;
Kobayashi, Miho;
Ibi, Haruka;
Uchida, Shizuka;
Iwabuchi, Sadahiro;
Harada, Hiroyuki;
Hashimoto, Shinichi;
Miyazono, Kohei;
Shirouzu, Mikako;
Watabe, Tetsuro

Publication type:

Article

KDM4B: A promising oncology therapeutic target.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 8, doi. 10.1111/cas.16005

By:

Ni, Fangjing;
Tang, Heting;
Cheng, Siteng;
Yu, Yaoyu;
Yuan, Zhihao;
Chen, Yingfei;
Zhang, Encheng;
Wang, Xiang

Publication type:

Article

ZPR1 is an immunodiagnostic biomarker and promotes tumor progression in esophageal squamous cell carcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 70, doi. 10.1111/cas.16004

By:

Sun, Guiying;
Ye, Hua;
Liu, Huijuan;
Li, Tiandong;
Li, Jiaxin;
Zhang, Xiaoyue;
Cheng, Yifan;
Wang, Keyan;
Shi, Jianxiang;
Dai, Liping;
Wang, Peng

Publication type:

Article

Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 59, doi. 10.1111/cas.16003

By:

Anami, Toshiki;
Pan, Cheng;
Fujiwara, Yukio;
Komohara, Yoshihiro;
Yano, Hiromu;
Saito, Yoichi;
Sugimoto, Masamichi;
Wakita, Daiko;
Motoshima, Takanobu;
Murakami, Yoji;
Yatsuda, Junji;
Takahashi, Naofumi;
Suzu, Shinya;
Asano, Kenichi;
Tamada, Koji;
Kamba, Tomomi

Publication type:

Article

Outcomes of COVID‐19 in multiple myeloma patients treated with daratumumab.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 237, doi. 10.1111/cas.16001

By:

Jin, Dian;
He, Jingsong;
Wu, Wenjun;
Han, Xiaoyan;
Le, Jing;
Shu, Wenxiu;
Fu, Jiaping;
Kong, Hongwei;
Wang, Gang;
Zhou, Xiujie;
Qu, Zhigang;
Cai, Zhen;
He, Donghua

Publication type:

Article

Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 125, doi. 10.1111/cas.15988

By:

Toyohara, Yusuke;
Taguchi, Ayumi;
Ishii, Yoshiyuki;
Yoshimoto, Daisuke;
Yamazaki, Miki;
Matsunaga, Hiroko;
Nakatani, Kazuma;
Hoshi, Daisuke;
Tsuchimochi, Saki;
Kusakabe, Misako;
Baba, Satoshi;
Kawata, Akira;
Ikemura, Masako;
Tanikawa, Michihiro;
Sone, Kenbun;
Uchino‐Mori, Mayuyo;
Ushiku, Tetsuo;
Takeyama, Haruko;
Oda, Katsutoshi;
Kawana, Kei

Publication type:

Article

Newly developed preclinical models reveal broad‐spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 283, doi. 10.1111/cas.15984

By:

Matsuoka, Takashi;
Sugiyama, Aiko;
Miyawaki, Yoshifumi;
Hidaka, Yusuke;
Okuno, Yukiko;
Sakai, Hiroaki;
Tanaka, Hiroki;
Yoshikawa, Kiyotsugu;
Fukui, Tomohiro;
Mizuno, Kei;
Sumiyoshi, Takayuki;
Goto, Takayuki;
Inoue, Takahiro;
Akamatsu, Shusuke;
Kobayashi, Takashi;
Nakamura, Eijiro

Publication type:

Article

SCD1 inhibition enhances the effector functions of CD8+ T cells via ACAT1‐dependent reduction of esterified cholesterol.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 48, doi. 10.1111/cas.15999

By:

Sugi, Toshihiro;
Katoh, Yuki;
Ikeda, Toshikatsu;
Seta, Daichi;
Iwata, Takashi;
Nishio, Hiroshi;
Sugawara, Masaki;
Kato, Daiki;
Katoh, Kanoko;
Kawana, Kei;
Yaguchi, Tomonori;
Kawakami, Yutaka;
Hirai, Shuichi

Publication type:

Article

Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 197, doi. 10.1111/cas.15994

By:

Morishima, Tatsuya;
Takahashi, Koichi;
Chin, Desmond Wai Loon;
Wang, Yuxin;
Tokunaga, Kenji;
Arima, Yuichiro;
Matsuoka, Masao;
Suda, Toshio;
Takizawa, Hitoshi

Publication type:

Article

Suggested role for neutrophil extracellular trap formation in Ewing sarcoma immune microenvironment.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 36, doi. 10.1111/cas.15992

By:

Shukrun, Rachel;
Baron, Szilvia;
Fidel, Victoria;
Shusterman, Anna;
Sher, Osnat;
Kollender, Netanya;
Levin, Dror;
Peled, Yair;
Gortzak, Yair;
Ben‐Shahar, Yoav;
Caspi, Revital;
Gordon, Sagi;
Manisterski, Michal;
Elhasid, Ronit

Publication type:

Article

Regulation of the innate immune response and gut microbiome by p53.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 184, doi. 10.1111/cas.15991

By:

Khor, Amy Hui Ping;
Koguchi, Tomoyuki;
Liu, Hao;
Kakuta, Masanori;
Matsubara, Daisuke;
Wen, Ruimeng;
Sagiya, Yoji;
Imoto, Seiya;
Nakagawa, Hidewaki;
Matsuda, Koichi;
Tanikawa, Chizu

Publication type:

Article

CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 139, doi. 10.1111/cas.15998

By:

Wei, Jianxia;
Li, Mengna;
Chen, Shipeng;
Xue, Changning;
Zheng, Lemei;
Duan, Yumei;
Deng, Hongyu;
Fan, Songqing;
Xiong, Wei;
Zhou, Ming

Publication type:

Article

Anti‐HTLV‐1 immunity combined with proviral load as predictive biomarkers for adult T‐cell leukemia‐lymphoma.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 310, doi. 10.1111/cas.15997

By:

Yamada, Asami;
Yasunaga, Jun‐ichirou;
Liang, Lihan;
Zhang, Wenyi;
Sunagawa, Junya;
Nakaoka, Shinji;
Iwami, Shingo;
Kogure, Yasunori;
Ito, Yuta;
Kataoka, Keisuke;
Nakagawa, Masanori;
Iwanaga, Masako;
Utsunomiya, Atae;
Koh, Ki‐Ryang;
Watanabe, Toshiki;
Nosaka, Kisato;
Matsuoka, Masao

Publication type:

Article

Impact of TP53‐induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 170, doi. 10.1111/cas.15981

By:

Toshida, Katsuya;
Itoh, Shinji;
Iseda, Norifumi;
Izumi, Takuma;
Yoshiya, Shohei;
Toshima, Takeo;
Ninomiya, Mizuki;
Iwasaki, Takeshi;
Oda, Yoshinao;
Yoshizumi, Tomoharu

Publication type:

Article

Development of T cell receptor‐engineered T cells targeting the sarcoma‐associated antigen papillomavirus binding factor.

Published in:

Cancer Science, 2024, v. 115, n. 1, p. 24, doi. 10.1111/cas.15967

By:

Hamada, Shuto;
Tsukahara, Tomohide;
Watanabe, Yuto;
Murata, Kenji;
Mizue, Yuka;
Kubo, Terufumi;
Kanaseki, Takayuki;
Hirohashi, Yoshihiko;
Emori, Makoto;
Nakatsugawa, Munehide;
Teramoto, Atsushi;
Yamashita, Toshihiko;
Torigoe, Toshihiko

Publication type:

Article

Issue Information.

Published in:: Cancer Science, 2024, v. 115, n. 1, p. 1, doi. 10.1111/cas.15857
Publication type:: Article

Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 1

Abstracts.

In this issue: Volume 115, Issue 1, January 2024.

Correction to: Steroid receptor coactivator‐1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR‐152/KLF4 pathway.

Role and function of plakophilin 3 in cancer progression and skin disease.

Retraction: Cui S‐Z, Lei Z‐Y, Guan T–P, et al. Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy. Cancer Science. 2020; 111: 1567–1581. https://doi.org/10.1111/cas.14375.

Neon ion (<sup>20</sup>Ne<sup>10</sup><sup>+</sup>) charged particle beams manipulate rapid tumor reoxygenation in syngeneic mouse models.

Serial comprehensive genomic profiling by next‐generation sequencing for patients with metastatic colorectal cancer.

A novel iTreg‐related signature for prognostic prediction in lung adenocarcinoma.

Antitumor activities against breast cancers by an afucosylated anti‐HER2 monoclonal antibody H<sub>2</sub>Mab‐77‐mG<sub>2a</sub>‐f.

T‐cell receptor sequencing reveals hepatocellular carcinoma immune characteristics according to Barcelona Clinic liver cancer stages within liver tissue and peripheral blood.

Detection and clinical significance of CEACAM5 methylation in colorectal cancer patients.

Autoantibody repertoire profiling in tissue and blood identifies colorectal cancer‐specific biomarkers.

Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer.

Extracellular vesicle‐encapsulated microRNA‐296‐3p from cancer‐associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways.

LINE‐1 hypomethylation, increased retrotransposition and tumor‐specific insertion in upper gastrointestinal cancer.

Inhibition of transforming growth factor‐β signals suppresses tumor formation by regulation of tumor microenvironment networks.

KDM4B: A promising oncology therapeutic target.

ZPR1 is an immunodiagnostic biomarker and promotes tumor progression in esophageal squamous cell carcinoma.

Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy.

Outcomes of COVID‐19 in multiple myeloma patients treated with daratumumab.

Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids.

Newly developed preclinical models reveal broad‐spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide.

SCD1 inhibition enhances the effector functions of CD8<sup>+</sup> T cells via ACAT1‐dependent reduction of esterified cholesterol.

Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells.

Suggested role for neutrophil extracellular trap formation in Ewing sarcoma immune microenvironment.

Regulation of the innate immune response and gut microbiome by p53.

CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene.

Anti‐HTLV‐1 immunity combined with proviral load as predictive biomarkers for adult T‐cell leukemia‐lymphoma.

Impact of TP53‐induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma.

Development of T cell receptor‐engineered T cells targeting the sarcoma‐associated antigen papillomavirus binding factor.

Issue Information.